ID   Neuro2A[TRa1]
AC   CVCL_E7G2
SY   Neuro2A[TRalpha1]; N2a-alpha; Neuro-2a TR-alpha
RX   PubMed=8146169;
RX   PubMed=39594637;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11796; THRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=8146169; DOI=10.1073/pnas.91.7.2644; PMCID=PMC43426;
RA   Lebel J.-M., Dussault J.H., Puymirat J.;
RT   "Overexpression of the beta 1 thyroid receptor induces differentiation
RT   in Neuro-2a cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:2644-2648(1994).
//
RX   PubMed=39594637; DOI=10.3390/cells13221889; PMCID=PMC11593031;
RA   Hergenhahn L., Padutsch N., Azawi S., Weiskirchen R., Liehr T.,
RA   Rincic M.;
RT   "Cytogenomic characterization of murine neuroblastoma cell line
RT   Neuro-2a and its two derivatives Neuro-2a TR-alpha and Neuro-2a
RT   TR-beta.";
RL   Cells 13:1889.1-1889.11(2024).
//